Treatment options for visceral leishmaniasis
- 1 April 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 4 (2) , 187-197
- https://doi.org/10.1586/14787210.4.2.187
Abstract
This review summarizes the current developments in therapy for visceral leishmaniasis. With the recent introduction of new drugs, the main limits in reducing deaths from visceral leishmaniasis are difficulty in diagnosis in the field and health inequality--patients lack of access to treatment. No new drugs are currently in the early stages of development. There are good reasons for the use of combination therapy; to prevent further development of resistance against the limited therapeutic options available.Keywords
This publication has 69 references indexed in Scilit:
- Treatment of visceral leishmaniasisExpert Opinion on Pharmacotherapy, 2005
- Advances in leishmaniasisPublished by Elsevier ,2005
- Clinical status of agents being developed for leishmaniasisExpert Opinion on Investigational Drugs, 2005
- Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Patients in Southern SudanClinical Infectious Diseases, 2004
- Single‐Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter StudyClinical Infectious Diseases, 2003
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial Commentary: cost and resistance remain issuesBMJ, 2001
- Discontinuation of secondary anti-Leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapyAIDS, 2000
- Avaliação comparativa da eficácia e toxicidade do antimoniato de N-metil-glucamina e do Estibogluconato de Sódio BP88® no tratamento da leishmaniose cutânea localizadaRevista da Sociedade Brasileira de Medicina Tropical, 2000
- Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopicaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992